Long Term Immunogenicity of the JE Vaccine IC51

Long Term Immunogenicity of the Japanese Encephalitis Vaccine IC51 (JE-PIV).

Status

Not yet recruiting

Phases

Phase 3

Study type

Interventional

Source

ANZCTR

Registry ID

ACTRN12605000681651

Enrollment

600

Registered

2005-10-21

Start date

2006-10-12

Completion date

Unknown

Last updated

2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

A Phase III follow-up study to assess long term safety 6 months after the first vacccination with IC51 and to assess in a subgroup the long term immunogenicity up to 24 months

Study design

Allocation

Non-randomised trial

Intervention model

Parallel

Primary purpose

Treatment

Masking

Blinded (masking used)

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

Healthy subjects. Written informed consent obtained prior to study entry.

Exclusion criteria

No exclusion criteria

Outcome results